This series began in July 2026. From "choosing skincare by feel" to "choosing skincare by evidence" — ever since we raised that banner, we have, week by week, put the science of skin into words: the triangle of sweat, sebum and pores; the rethinking of the 28-day turnover myth; the grading of PDRN and exosome hype; the division of labor among the dermis's three pillars. In this final article of the year, we will not talk about selling products. Instead, we state plainly where KAIAN intends to go in 2027.
Our brand philosophy has been consistent. We do not aim to "cure" aging; we aim to preserve skin's function. This is Skin Longevity — extending the functional lifespan of the skin. Rather than categorical promises to erase wrinkles or remove spots, we scientifically support keeping the skin's innate barrier, renewal, and homeostatic functions healthy for as long as possible. This stance will not change in 2027. If anything, we will dig deeper.
1. Looking Back — What Counted as "Lasting Science"
In 2026, countless ingredients trended on social media, and we graded them frankly by the strength of their evidence. Ingredients backed by decades of clinical research — such as retinol, niacinamide, and ascorbic acid derivatives — are "lasting science," independent of any trend. Meanwhile, regenerative-medicine-derived ingredients like exosomes and PDRN have robust injectable data, but their topical (transdermal) evidence is still developing — and we have said so honestly.
Trending ingredients and lasting science are not the same. The size of the buzz says nothing about the strength of the evidence. The discernment to tell them apart is what we most wanted to convey this year.
At the same time, the longevity-science family — NMN, resveratrol, spermidine, urolithin A — drew attention, with mechanisms reported in basic research around cellular energy metabolism, autophagy, and effects on aged cells. This is a domain closely aligned with the idea of skin's "functional lifespan." Yet human topical studies as cosmetics remain limited, and over-expectation is unwise. We will not blur this distinction in 2027 either.
2. Where Will the Science of Functional Lifespan Evolve?
Skin aging cannot be explained by a single cause. Photoaging, glycation, oxidative stress, loss of the extracellular matrix, and the recently spotlighted accumulation of senescent cells — multiple pathways intertwine. One area of expected progress in 2027 is the approach to these senescent cells. Basic research has reported the concept of "senolytics" — selectively clearing aged cells — with flavonoids such as fisetin and quercetin studied as candidates. In cosmetics, formulation with senolytic actives is being explored, but proof of efficacy on human skin lies ahead.
A second axis is interest in NAD+, the energetic foundation of cells. nicotinamide riboside, NAD+ boosters, and the cofactor PQQ are under study as pathways tied to mitochondrial function and cellular energy metabolism. Furthermore, the polyamine spermidine has been reported as possibly promoting autophagy — cellular self-cleansing. None of these are about "forcing rejuvenation"; they align with the functional-lifespan idea of helping cells sustain their innate work for longer. We will keep following this domain — without exaggeration, but without timidity.
3. AI Skin Diagnostics and Personalization — Toward "Your Skin"
In 2027, what we most want to invest in is translating science into "your skin." This series has conveyed the universal principles of skin science. But real skin differs from person to person by age, genetics, lifestyle, season, and region. The same retinol can be appropriate active care for one person and too irritating for another. Even the same dryness may stem chiefly from a deficit of ceramides in one person, and from issues with natural moisturizing factors like hyaluronic acid and sodium PCA in another.
Here AI skin diagnostics and personalization have a role: objectively assessing skin condition from image analysis and data, bridging universal science to individualized recommendations. But caution is needed. AI diagnosis depends heavily on the quality of its input and training data and, at present, does not replace medical diagnosis. We will cultivate AI carefully — not as a "magic answer," but as a tool that supports evidence-based choices. For barrier support, panthenol and madecassoside; for antioxidation, tocopherol and astaxanthin — even the selection of such ingredients should ultimately be optimized for "that person's skin."
4. Practicing Functional Lifespan, Starting Today
Before waiting for future science, there is much you can do now. Practicing Skin Longevity is not flashy. It is the accumulation of daily habits.
- The fundamentals of defense — keep sun protection going year-round. Because photoaging accumulates, it is the surest "savings" for functional lifespan.
- Don't break the barrier — use active ingredients at the right dose and frequency. Build the foundation with ceramides and panthenol before going on the offensive.
- Make antioxidation a habit — prepare for daytime oxidative stress with ascorbic acid derivatives and ferulic acid.
- Choose by evidence — judge ingredients by the accumulation of research, not by buzz.
Extending functional lifespan is not about doing something special — it is about not stripping the skin of the power it already has. The science of defense is the surest offense.
5. Our Promise as an Education-First Brand
Finally, let us restate where KAIAN stands. We do not make categorical drug-like efficacy claims for cosmetics. We write plainly that strongly evidenced ingredients are strong, and weakly evidenced ones are weak. We do not deny trends, but we do not confuse trends with science. Regarding our own brand EVOLURE, in areas not yet launched we will honestly say "currently not offered" and will not hard-sell. Even if you choose another company's product, we want to support that choice scientifically, from the standpoint of ingredients and specifications.
In 2027, the science of extending skin's functional lifespan will advance toward the convergence of longevity-ingredient exploration, new approaches to senescent cells, and AI-driven personalization. We will verify each step with you — without exaggeration, but with unflagging curiosity. That is KAIAN's mission as an education-first brand. To you, who have read this series for a year: next year too, let us walk the journey of choosing by evidence, together.
The Evidence-Concentration Lens
The ingredients here matter not by whether they are "present," but by whether they appear at the concentration shown to work. Learn how to read the label in The Lens of Evidence Concentration.
References
Key peer-reviewed sources behind the scientific statements in this article.
- Eisenberg T, Knauer H, Schauer A, et al. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol. 2009;11(11):1305–1314. PubMed
- Yousefzadeh MJ, Zhu Y, McGowan SJ, et al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine. 2018;36:18–28. PubMed
- Zhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14(4):644–658. PubMed